Cargando…

Editorial: Immune-related adverse events for patients with lung cancer-volume II

Detalles Bibliográficos
Autores principales:	Wang, Yusha, Wang, Xia, Zhan, Cheng, Frey, Benjamin, Gaipl, Udo S., Shi, Hubing, Ma, Xuelei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665083/ https://www.ncbi.nlm.nih.gov/pubmed/38023236 http://dx.doi.org/10.3389/fonc.2023.1282394

Ejemplares similares

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
por: Yang, Ruoning, et al.
Publicado: (2022)

Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II
por: Li, Yueyi, et al.
Publicado: (2023)

Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation
por: Christopoulos, Petros, et al.
Publicado: (2023)

Editorial to Radiation in Multimodal Tumor Immune Therapies—Mechanisms and Application
por: Frey, Benjamin, et al.
Publicado: (2021)

Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
por: Deloch, Lisa, et al.
Publicado: (2016)

Editorial: Radiation and the Immune System: Current Knowledge and Future Perspectives
por: Lumniczky, Katalin, et al.
Publicado: (2018)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis
por: Wang, Donghui, et al.
Publicado: (2021)

Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II
por: Burnett, Deborah L., et al.
Publicado: (2023)

Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors
por: Rapoport, Bernardo Leon
Publicado: (2019)

How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
por: Rubner, Yvonne, et al.
Publicado: (2012)

Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells
por: Gehre, Simon, et al.
Publicado: (2023)

Arthralgia adverse events due to immune-checkpoint inhibitors for lung cancer patients: a systematic review and meta-analysis
por: Zou, Defang, et al.
Publicado: (2023)

Editorial: Biomarkers in genitourinary cancers: Volume II
por: Yuasa, Takeshi
Publicado: (2022)

Frontiers Research Topic: Radiation-Induced Effects and the Immune System
por: Multhoff, Gabriele, et al.
Publicado: (2013)

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy
por: Yin, Xiaoran, et al.
Publicado: (2023)

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer
por: Hou, Wanting, et al.
Publicado: (2021)

Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment
por: Seitz, Christoph, et al.
Publicado: (2019)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Editorial: Women in gastrointestinal cancers, volume II: 2022
por: Hamdy, Nadia M., et al.
Publicado: (2023)

Editorial: Targeting the PD-1/PD-L1 cancer immune evasion axis: Challenges and emerging strategies, Volume II
por: He, Xiujing, et al.
Publicado: (2022)

Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
por: Burke, Michael, et al.
Publicado: (2021)

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II
por: Lu, Qisi, et al.
Publicado: (2023)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: Women in molecular and cellular oncology, volume II: 2022
por: Dhar, Shilpa S.
Publicado: (2023)

Editorial: Gastrointestinal cancer immune response and immune related adverse effects
por: Wen, Ti, et al.
Publicado: (2022)

Graphene-Induced Hyperthermia (GIHT) Combined With Radiotherapy Fosters Immunogenic Cell Death
por: Podolska, Malgorzata J., et al.
Publicado: (2021)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment
por: Zheng, Xiaohu, et al.
Publicado: (2021)

Immunomodulatory Properties and Molecular Effects in Inflammatory Diseases of Low-Dose X-Irradiation
por: Rödel, Franz, et al.
Publicado: (2012)

Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors
por: Schubert, Philipp, et al.
Publicado: (2020)

Editorial: Molecular advances in diagnosis and treatment of CNS tumors, volume II
por: Chen, Clark, et al.
Publicado: (2023)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
por: Al-Rajabi, Taiseer, et al.
Publicado: (2023)

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer
por: Daniello, Lea, et al.
Publicado: (2021)

Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90
por: Ernst, Anne, et al.
Publicado: (2020)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Editorial: Meningioma: From basic research to clinical translational study, volume II
por: Tang, Hailiang, et al.
Publicado: (2023)

Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas, Volume II
por: Bosio, Alberto, et al.
Publicado: (2023)

Immune-Related Adverse Events: A Case-Based Approach
por: Connolly, Caoilfhionn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5m2n3hdcjt75on345p3lqeseir